Showing results (1761-1770 of 1,862) with videos related to

Sort By:
Pageof 187
Science Translational Medicine|July 31, 2015
Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infectionTakuya Yamamoto, Rebecca M Lynch, Rajeev Gautam, et al.
Journal of Pediatric Urology|June 9, 2026
Establishing a clinician-prioritized pediatric urology clinical research agenda in the United StatesLauren E Corona, Courtney S Streur, Jennifer J Ahn, et al.
Nature Communications|December 10, 2022
Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementiaMarie-Laure Charpignon, Bella Vakulenko-Lagun, Bang Zheng, et al.
The Lancet. Neurology|February 1, 2017
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trialVincent Meininger, Angela Genge, Leonard H van den Berg, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
The functional landscape of the human ubiquitinomeJulian van Gerwen, Maximilian Fottner, Shengbo Wang, et al.
Nature Communications|December 2, 2023
Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primatesChaim A Schramm, Damee Moon, Lowrey Peyton, et al.
Molecular & Cellular Proteomics : MCP|April 22, 2026
A landscape analysis of human SUMOylationShireen S Al-Momani, Kerry Rambsbottom, Andrew Collins, et al.
The Journal of Experimental Medicine|January 10, 2001
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infectionM Altfeld, E S Rosenberg, R Shankarappa, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.
Pain Physician|July 20, 2006
Interventional techniques in the management of chronic spinal pain: evidence-based practice guidelinesMark V Boswell, Rinoo V Shah, Clifford R Everett, et al.
Pageof 187